Published Aug 4, 2026, 9:06 PM ET · Updated 3 months ago · 1 source

Goldman-Backed Biotech Attovia Raises $289 Million in US IPO

bloomberg

Original Report

Attovia Therapeutics Inc., an early-stage drug developer focused on immune system diseases with high unmet need, raised $289 million in a US initial public offering that priced at the top of its marketed range.